Sergey Aleksandrovich Il'CHenko
Research Subjects
Sergey Aleksandrovich Il'CHenko has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Oleg Ivanovich Kit
National Medical Research Centre for Oncology, Rostov-on-Don, Russia
11 shared publications - Irina Valer'EVna Neskubina
National Medical Research Center of Oncology, Ministry of Health of Russia
8 shared publications - Elena Mikhaylovna Frantsiyants
National Medical Research Center of Oncology, Ministry of Health of Russia
7 shared publications - Alla Ivanovna Shikhlyarova
National Medical Research Center of Oncology, Ministry of Health of Russia
6 shared publications - Valeriya Akhtyamovna Bandovkina
National Medical Research Center of Oncology, Ministry of Health of Russia
5 shared publications - Aleksandr V. Shaposhnikov
National Medical Research Centre for Oncology
3 shared publications
Latest Publications
- Open Access
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 6-22
The level of antioxidants, 8OHDG, and mitochondrial membrane potential of tumor tissues depending on the location of colorectal cancer
Purpose of the study. To study the mitochondrial membrane potential, indicators of the enzymatic and non-enzymatic antioxidant systems, and the mtDNA damage index in the mitochondria of colorectal cancer (CRC) cells depending on its location, the presence of metastases in the lymph nodes, and the patient sex. Patients and methods. The study included results obtained from 132 patients (52 women and 80 men) with T2–3N0M0 colon cancer. Mitochondria from intestinal and tumor tissue cells were isolated using differential centrifugation. The concentration of SOD-2, 8OHdG, vitamins A and E, GPO-1, and the membrane potential (ΔψM) were determined in mitochondria. Statistical analysis was performed using the program Statistica 10.0. Results. In rectal tumor mitochondria with lymph node metastases, both men and women demonstrated increased 8-OHdG levels and decreased ΔψM compared with patients without lymph node metastases: in men, by 2.2-fold and 1.5-fold (p < 0.05), and in women, by 1.3-fold (p < 0.05) and 2.0-fold, respectively. In the left colon, tumor mitochondria in men with metastases showed a 2.4-fold increase in 8-OHdG, while ΔψM and vitamins A and E levels were reduced by 1.7-fold (p < 0.05), 2.4-fold, and 3.1-fold, respectively. In women, lymph node metastases were associated with decreased levels of vitamins A and E by 1.7-fold (p < 0.05) and 4.3-fold. In the right colon, tumor mitochondria in patients with metastases showed higher levels of vitamins A and E compared with those without metastases: vitamin A increased by 1.7-fold (p < 0.05) in men and 2.4-fold in women, and vitamin E by 4.2-fold and 3.9-fold, respectively. SOD-2 levels were 2.2-fold lower only in tumor mitochondria with metastases in men.
- 7 June 2026
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 7 (2) , 6-22
Open AccessThe level of antioxidants, 8OHDG, and mitochondrial membrane potential of tumor tissues depending on the location of colorectal cancer
Purpose of the study. To study the mitochondrial membrane potential, indicators of the enzymatic and non-enzymatic antioxidant systems, and the mtDNA damage index in the mitochondria of colorectal cancer (CRC) cells depending on its location, the presence of metastases in the lymph nodes, and the patient sex. Patients and methods. The study included results obtained from 132 patients (52 women and 80 men) with T2–3N0M0 colon cancer. Mitochondria from intestinal and tumor tissue cells were isolated using differential centrifugation. The concentration of SOD-2, 8OHdG, vitamins A and E, GPO-1, and the membrane potential (ΔψM) were determined in mitochondria. Statistical analysis was performed using the program Statistica 10.0. Results. In rectal tumor mitochondria with lymph node metastases, both men and women demonstrated increased 8-OHdG levels and decreased ΔψM compared with patients without lymph node metastases: in men, by 2.2-fold and 1.5-fold (p < 0.05), and in women, by 1.3-fold (p < 0.05) and 2.0-fold, respectively. In the left colon, tumor mitochondria in men with metastases showed a 2.4-fold increase in 8-OHdG, while ΔψM and vitamins A and E levels were reduced by 1.7-fold (p < 0.05), 2.4-fold, and 3.1-fold, respectively. In women, lymph node metastases were associated with decreased levels of vitamins A and E by 1.7-fold (p < 0.05) and 4.3-fold. In the right colon, tumor mitochondria in patients with metastases showed higher levels of vitamins A and E compared with those without metastases: vitamin A increased by 1.7-fold (p < 0.05) in men and 2.4-fold in women, and vitamin E by 4.2-fold and 3.9-fold, respectively. SOD-2 levels were 2.2-fold lower only in tumor mitochondria with metastases in men.
- Open Access
- 15 October 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (3) , 42-51
Ultrastructural aspects of mitochondrial translocation in colorectal cancer as a possible pathway of tumorigenesis
Aim. To study the ultrastructural features of rectal cancer cells and to detect signs of mitochondrial translocation from the tumor to the resection line area with an assessment of the possibility of the formation of new malignant cells. Materials and methods. The present study encompassed the data obtained from 44 patients with an average age of 66 (58–73) years, who underwent surgical intervention for rectal cancer T2–3N0M0 with differentiation grade G2. A portion of the tumor specimen and intestinal tissue along the resection line were preserved in a formaldehyde-glutaraldehyde fixative solution. Standard methods of section preparation were employed. Sections were subsequently examined using a Jeol JEM-1011 electron microscope (JEOL Inc., Japan).Results. The ultrastructure of rectal adenocarcinoma was characterized by a high density of arrangement and varying sizes and shapes of tumor cells with a large nucleus and deep invaginations of the nuclear membrane, as well as an accumulation of multiple mitochondria at one of the cell poles. The process of pinching off a cytoplasmic fragment, which was found to be densely packed with mitochondria, was observed. This phenomenon was subsequently identified as a mitochondriome. Following this observation, the mitochondria were found to have translocated into healthy intestinal tissues along the resection line. Electron diffraction data revealed the active movement of mitochondria in the form of small spheroids and mitovesicles along the boundaries of the multilayer structure of the rectal submucosa, and subsequent fusion into large organelles capable of implementing nuclear synthesis from transported mitochondrial and nuclear DNA. We observed the presence of individual nuclear structures in conjunction with groups of mitochondria, followed by the self-assembly of abnormal cells.Conclusion. The ultrastructural analysis of rectal adenocarcinoma indicates the need for mitochondrial translocation to free up intracellular space and prevent the metabolic threat of reactive oxygen species (ROS) accumulation in tumor cells. It also points to the key role of mitochondria in initiating tumor energy and information transfer as leaders of these processes. This observation suggests the possibility of early recurrence and metastasis in rectal cancer cases.
- 15 October 2025
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 24 (3) , 42-51
Open AccessUltrastructural aspects of mitochondrial translocation in colorectal cancer as a possible pathway of tumorigenesis
Aim. To study the ultrastructural features of rectal cancer cells and to detect signs of mitochondrial translocation from the tumor to the resection line area with an assessment of the possibility of the formation of new malignant cells. Materials and methods. The present study encompassed the data obtained from 44 patients with an average age of 66 (58–73) years, who underwent surgical intervention for rectal cancer T2–3N0M0 with differentiation grade G2. A portion of the tumor specimen and intestinal tissue along the resection line were preserved in a formaldehyde-glutaraldehyde fixative solution. Standard methods of section preparation were employed. Sections were subsequently examined using a Jeol JEM-1011 electron microscope (JEOL Inc., Japan).Results. The ultrastructure of rectal adenocarcinoma was characterized by a high density of arrangement and varying sizes and shapes of tumor cells with a large nucleus and deep invaginations of the nuclear membrane, as well as an accumulation of multiple mitochondria at one of the cell poles. The process of pinching off a cytoplasmic fragment, which was found to be densely packed with mitochondria, was observed. This phenomenon was subsequently identified as a mitochondriome. Following this observation, the mitochondria were found to have translocated into healthy intestinal tissues along the resection line. Electron diffraction data revealed the active movement of mitochondria in the form of small spheroids and mitovesicles along the boundaries of the multilayer structure of the rectal submucosa, and subsequent fusion into large organelles capable of implementing nuclear synthesis from transported mitochondrial and nuclear DNA. We observed the presence of individual nuclear structures in conjunction with groups of mitochondria, followed by the self-assembly of abnormal cells.Conclusion. The ultrastructural analysis of rectal adenocarcinoma indicates the need for mitochondrial translocation to free up intracellular space and prevent the metabolic threat of reactive oxygen species (ROS) accumulation in tumor cells. It also points to the key role of mitochondria in initiating tumor energy and information transfer as leaders of these processes. This observation suggests the possibility of early recurrence and metastasis in rectal cancer cases.
- Open Access
- 9 September 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (3) , 26-34
Features of the cell cycle in patients with colorectal cancer
Purpose of the study. The objective of this study was to evaluate cell cycle indices in tumor cells and conditionally intact intestinal tissue (resection line) in male and female patients with colorectal cancer (CRC).Patients and methods. Cell cycle phases were analyzed in 36 male and 36 female patients with CRC involving the rectum, and with right-sided or left-sided tumor localization. The mean age was 66 years. The degree of tumor differentiation in all cases corresponded to G2. None of the patients had received neoadjuvant treatment before surgery. In 10 % of tumor homogenates and resection line samples, cell cycle phases were determined using an ADAMII LS fluorescent cell analyzer (Korea). For cell cycle analysis, propidium iodide (PI), specially prepared for the ADAMII LS, was used. This reagent mixture contained PI and RNaseA, and cells were stained directly without an additional fixation step. The instrument’s high sensitivity enabled precise discrimination of cells in the G0/G1 phase (resting cells [G0] and early G1), S phase, and G2/M phase. Statistical analysis was performed using Statistica 10.0 software.Results. The proportions of viable and dead cells in the samples were generally comparable. In men, viable cells ranged from 56.6 % to 73.6 %, and dead cells from 26.4 % to 43.4 %. In women, viable cells ranged from 60.8 % to 77.3 %, and dead cells from 22.7 % to 39.2 %. In men, tumor samples from left-sided CRC contained predominantly S and G2 phase cells, whereas in right-sided CRC and rectal tumors, the majority of cells were in the G1 phase. In women with left-sided CRC, tumor samples showed the highest proportion of cells in the G1 phase, while samples from right-sided CRC and rectal tumors contained predominantly S phase cells.Conclusion. The identified cell cycle characteristics and tumor cell death patterns in CRC patients, depending on sex and tumor localization, reflect the proliferative status of the tissue. These findings may provide a basis for personalized recommendations on the use of antitumor agents targeting cells in specific cell cycle phases.
- 9 September 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (3) , 26-34
Open AccessFeatures of the cell cycle in patients with colorectal cancer
Purpose of the study. The objective of this study was to evaluate cell cycle indices in tumor cells and conditionally intact intestinal tissue (resection line) in male and female patients with colorectal cancer (CRC).Patients and methods. Cell cycle phases were analyzed in 36 male and 36 female patients with CRC involving the rectum, and with right-sided or left-sided tumor localization. The mean age was 66 years. The degree of tumor differentiation in all cases corresponded to G2. None of the patients had received neoadjuvant treatment before surgery. In 10 % of tumor homogenates and resection line samples, cell cycle phases were determined using an ADAMII LS fluorescent cell analyzer (Korea). For cell cycle analysis, propidium iodide (PI), specially prepared for the ADAMII LS, was used. This reagent mixture contained PI and RNaseA, and cells were stained directly without an additional fixation step. The instrument’s high sensitivity enabled precise discrimination of cells in the G0/G1 phase (resting cells [G0] and early G1), S phase, and G2/M phase. Statistical analysis was performed using Statistica 10.0 software.Results. The proportions of viable and dead cells in the samples were generally comparable. In men, viable cells ranged from 56.6 % to 73.6 %, and dead cells from 26.4 % to 43.4 %. In women, viable cells ranged from 60.8 % to 77.3 %, and dead cells from 22.7 % to 39.2 %. In men, tumor samples from left-sided CRC contained predominantly S and G2 phase cells, whereas in right-sided CRC and rectal tumors, the majority of cells were in the G1 phase. In women with left-sided CRC, tumor samples showed the highest proportion of cells in the G1 phase, while samples from right-sided CRC and rectal tumors contained predominantly S phase cells.Conclusion. The identified cell cycle characteristics and tumor cell death patterns in CRC patients, depending on sex and tumor localization, reflect the proliferative status of the tissue. These findings may provide a basis for personalized recommendations on the use of antitumor agents targeting cells in specific cell cycle phases.
- Open Access
- 9 June 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (2) , 14-21
Apoptosis-Inducing Factor (AIF) content in tumor cell mitochondria from colorectal cancer patients
Purpose of the study. To investigate the level of protein AIF in the mitochondria of tumor cells and visually unchanged tissues of the colon in male and female patients with colorectal cancer.Materials and methods. The study included results, obtained from 132 patients with stage T2–3N0M0 colon cancer, comprising 52 women and 80 men. Mitochondria were isolated from human colon and tumor tissue cells using differential centrifugation in a high-speed refrigerated centrifuge. The concentration of protein AIF (pg/mg protein) in mitochondria was determined using ELISA «Human AIF Elisa Kit» (Cloud-CloneCorp., China).Results. It was established that in males, the AIF level in the mitochondria of rectal, sigmoid colon and ascending colon tumor cells was 2.4 times, 1.9 times (p < 0.05) and 3.1 times higher, respectively, than in the mitochondria of the corresponding tissues not affected by the tumor. In the mitochondria of the intestinal tissue not affected by the tumor, significant differences in the AIF content were observed, with levels varying depending on the anatomical location. In the sigmoid colon, the level of this factor was found to be 1.9 (p < 0.05) and 2.6 times higher than in the rectum and ascending colon, respectively. Concurrently, no notable discrepancies in the AIF concentration within the mitochondria of conditionally unimpaired tissues were observed in the female subjects. The AIF content was found to be higher in the mitochondria of tumor cells in women than in conditionally intact tissues. Specifically, it was observed to be 2.1 times higher in rectal tumors, 4.4 times higher in sigmoid colon tumors and 1.7 times (p < 0.05) higher in ascending colon tumors. Significant discrepancies in the AIF content between men and women, as well as between the mitochondria of tumor sample cells, were identified. In the rectal and ascending colon tumor, the AIF level in women was found to be markedly elevated in comparison to men, exhibiting a ratio of 1.3 (p < 0.05) and 2.4, respectively.Conclusion. In patients with colorectal cancer, the content of AIF in tumor mitochondria is observed to increase. This can be considered to represent stimulation mechanism of tumor proliferative activity due to its NADH/NADPH oxidase function, which promotes the survival of malignant cells.
- 9 June 2025
- Published by ANO -Perspective of Oncology in South Russian Journal of Cancer
- Vol. 6 (2) , 14-21
Open AccessApoptosis-Inducing Factor (AIF) content in tumor cell mitochondria from colorectal cancer patients
Purpose of the study. To investigate the level of protein AIF in the mitochondria of tumor cells and visually unchanged tissues of the colon in male and female patients with colorectal cancer.Materials and methods. The study included results, obtained from 132 patients with stage T2–3N0M0 colon cancer, comprising 52 women and 80 men. Mitochondria were isolated from human colon and tumor tissue cells using differential centrifugation in a high-speed refrigerated centrifuge. The concentration of protein AIF (pg/mg protein) in mitochondria was determined using ELISA «Human AIF Elisa Kit» (Cloud-CloneCorp., China).Results. It was established that in males, the AIF level in the mitochondria of rectal, sigmoid colon and ascending colon tumor cells was 2.4 times, 1.9 times (p < 0.05) and 3.1 times higher, respectively, than in the mitochondria of the corresponding tissues not affected by the tumor. In the mitochondria of the intestinal tissue not affected by the tumor, significant differences in the AIF content were observed, with levels varying depending on the anatomical location. In the sigmoid colon, the level of this factor was found to be 1.9 (p < 0.05) and 2.6 times higher than in the rectum and ascending colon, respectively. Concurrently, no notable discrepancies in the AIF concentration within the mitochondria of conditionally unimpaired tissues were observed in the female subjects. The AIF content was found to be higher in the mitochondria of tumor cells in women than in conditionally intact tissues. Specifically, it was observed to be 2.1 times higher in rectal tumors, 4.4 times higher in sigmoid colon tumors and 1.7 times (p < 0.05) higher in ascending colon tumors. Significant discrepancies in the AIF content between men and women, as well as between the mitochondria of tumor sample cells, were identified. In the rectal and ascending colon tumor, the AIF level in women was found to be markedly elevated in comparison to men, exhibiting a ratio of 1.3 (p < 0.05) and 2.4, respectively.Conclusion. In patients with colorectal cancer, the content of AIF in tumor mitochondria is observed to increase. This can be considered to represent stimulation mechanism of tumor proliferative activity due to its NADH/NADPH oxidase function, which promotes the survival of malignant cells.
- Open Access
- 1 March 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 26-39
Mitochondrial apoptosis factors in colorectal cancer tissue
Purpose of the study. To examine the influence of specific factors on the apoptosis process in the mitochondria of cells located in various regions of the colon, with a focus on patients of both sexes. Patients and methods. The study included results obtained from 132 patients with T2–3N0M0 colon cancer, comprising 52 women and 80 men. Mitochondria were isolated from human intestinal and tumor tissue cells using differential centrifugation. The concentration of cytochrome C (ng/mg protein), AIF (pg/mg protein), Bcl-2 (pg/mg protein), and calcium (mM/mg protein) were determined. Results. In men, the calcium level in the mitochondria of both rectal tumor tissue and left colon tumor tissue was reduced relative to the corresponding tissue along the resection line, while the levels of Bcl-2, cytochrome C, and AIF were, on the contrary, in creased. At the same time, the calcium and Bcl-2 levels in the mitochondria of the right colon tumor tissue did not differ statistically significantly from the corresponding values in the right colon tissue along the resection line, while the levels of cytochrome C and AIF were increased by 2.0 and 3.1 times. The calcium level was observed to be reduced by a factor of 1.5 in the mitochondria of rectal tumor tissue cells in women, in comparison to the indicator in the rectal tissue along the resection line (p < 0.05). The levels of Bcl-2, Cytochrome C, and AIF were increased by 1.5, 2.9, and 2.1 times, respectively. In the mitochondria of tumor tissue in the left half of the colon of women, the calcium level was reduced relative to the indicator in the tissue of the left half of the colon along the resection line by 1.6 times (p < 0.05), and AIF was statistically significantly increased by 2.7 times. In women, the levels of cytochrome C and AIF in the mitochondria of tumor tissue cells in the right half of the colon were 2.0 and 1.7 times higher, respectively, than the corresponding indicators in the tissue of the right half of the colon along the resection line (p < 0.05). Conclusion. A comprehensive analysis of the studied indicators suggests that apoptosis is suppressed in all regions of the large intestine in both men and women. Conversely, the processes of respiration and mitochondrial energy production appear to be enhanced.
- 1 March 2025
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 12 (1) , 26-39
Open AccessMitochondrial apoptosis factors in colorectal cancer tissue
Purpose of the study. To examine the influence of specific factors on the apoptosis process in the mitochondria of cells located in various regions of the colon, with a focus on patients of both sexes. Patients and methods. The study included results obtained from 132 patients with T2–3N0M0 colon cancer, comprising 52 women and 80 men. Mitochondria were isolated from human intestinal and tumor tissue cells using differential centrifugation. The concentration of cytochrome C (ng/mg protein), AIF (pg/mg protein), Bcl-2 (pg/mg protein), and calcium (mM/mg protein) were determined. Results. In men, the calcium level in the mitochondria of both rectal tumor tissue and left colon tumor tissue was reduced relative to the corresponding tissue along the resection line, while the levels of Bcl-2, cytochrome C, and AIF were, on the contrary, in creased. At the same time, the calcium and Bcl-2 levels in the mitochondria of the right colon tumor tissue did not differ statistically significantly from the corresponding values in the right colon tissue along the resection line, while the levels of cytochrome C and AIF were increased by 2.0 and 3.1 times. The calcium level was observed to be reduced by a factor of 1.5 in the mitochondria of rectal tumor tissue cells in women, in comparison to the indicator in the rectal tissue along the resection line (p < 0.05). The levels of Bcl-2, Cytochrome C, and AIF were increased by 1.5, 2.9, and 2.1 times, respectively. In the mitochondria of tumor tissue in the left half of the colon of women, the calcium level was reduced relative to the indicator in the tissue of the left half of the colon along the resection line by 1.6 times (p < 0.05), and AIF was statistically significantly increased by 2.7 times. In women, the levels of cytochrome C and AIF in the mitochondria of tumor tissue cells in the right half of the colon were 2.0 and 1.7 times higher, respectively, than the corresponding indicators in the tissue of the right half of the colon along the resection line (p < 0.05). Conclusion. A comprehensive analysis of the studied indicators suggests that apoptosis is suppressed in all regions of the large intestine in both men and women. Conversely, the processes of respiration and mitochondrial energy production appear to be enhanced.
- 27 December 2024
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 4
CHARACTERISTICS OF MITOCHONDRIAL CYTOCHROME C DISTRIBUTION IN PATIENTS WITH COLORECTAL CANCER
Understanding the mechanisms of colorectal cancer development and progression is important for disease management. Mitochondria being the energy source of eukaryotic cells play a significant role in intestinal homeostasis. Objective: The aim of the study is to examine cytochrome C level in mitochondria isolated from cells of different parts of the colon in men and women. Materials and Methods. The authors analyzed the materials obtained from 132 patients with colon cancer T2-3N0M0 (52 women and 80 men). Mitochondria from human intestinal and tumor tissue cells were isolated by differential centrifugation. Then, cytochrome C concentration (ng/mg protein) was determined by ELISA. Results. When studying the cytochrome C level in tumor tissue from various parts of the colon in men, we found that cytochrome C level in tumor mitochondria of the rectum, sigmoid colon and ascending colon was higher than that in the mitochondrial cells of the corresponding tissues by 1.8, 1.5 and 2.0 times, respectively. In women, cytochrome C level in the mitochondrial tumors of the same parts of the colon was higher than that in the mitochondria of the corresponding tissues by 2.9, 1.4 and 2.0 times, respectively. Conclusion. A common pathological characteristics of tumor mitochondria in all parts of the colon was a high cytochrome C level. It may be associated with the intensification of cellular respiration processes in the tumor contributing to its growth.
- 27 December 2024
- Published by Ulyanovsk State University in Ulyanovsk Medico-biological Journal
- No. 4
CHARACTERISTICS OF MITOCHONDRIAL CYTOCHROME C DISTRIBUTION IN PATIENTS WITH COLORECTAL CANCER
Understanding the mechanisms of colorectal cancer development and progression is important for disease management. Mitochondria being the energy source of eukaryotic cells play a significant role in intestinal homeostasis. Objective: The aim of the study is to examine cytochrome C level in mitochondria isolated from cells of different parts of the colon in men and women. Materials and Methods. The authors analyzed the materials obtained from 132 patients with colon cancer T2-3N0M0 (52 women and 80 men). Mitochondria from human intestinal and tumor tissue cells were isolated by differential centrifugation. Then, cytochrome C concentration (ng/mg protein) was determined by ELISA. Results. When studying the cytochrome C level in tumor tissue from various parts of the colon in men, we found that cytochrome C level in tumor mitochondria of the rectum, sigmoid colon and ascending colon was higher than that in the mitochondrial cells of the corresponding tissues by 1.8, 1.5 and 2.0 times, respectively. In women, cytochrome C level in the mitochondrial tumors of the same parts of the colon was higher than that in the mitochondria of the corresponding tissues by 2.9, 1.4 and 2.0 times, respectively. Conclusion. A common pathological characteristics of tumor mitochondria in all parts of the colon was a high cytochrome C level. It may be associated with the intensification of cellular respiration processes in the tumor contributing to its growth.
- Open Access
- 10 July 2024
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 23 (2) , 123-132
The role of estrogens in mitochondrial metabolism
Central organelles in cells are mitochondria, which are essential for many fundamental biological processes. In the course of evolution, mitochondria have been transformed into signaling centers in biological systems that can cause changes in the cell via secreted factors and affect physiology of humans and animals. Along with performing many key functions for the cell, mitochondria have also evolved into active hubs that can both control cellular programs through interaction with other compartments, such as the endoplasmic reticulum, and affect tissues, determining the health of the body via mechanisms that we are only beginning to understand.
- 10 July 2024
- Published by Siberian State Medical University in Bulletin of Siberian Medicine
- Vol. 23 (2) , 123-132
Open AccessThe role of estrogens in mitochondrial metabolism
Central organelles in cells are mitochondria, which are essential for many fundamental biological processes. In the course of evolution, mitochondria have been transformed into signaling centers in biological systems that can cause changes in the cell via secreted factors and affect physiology of humans and animals. Along with performing many key functions for the cell, mitochondria have also evolved into active hubs that can both control cellular programs through interaction with other compartments, such as the endoplasmic reticulum, and affect tissues, determining the health of the body via mechanisms that we are only beginning to understand.
- Open Access
- 16 February 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (1) , 40-53
Extracellular mitochondria as promising diagnostic agents
Nowadays, there is a new concept that says that mitochondria naturally circulate in the blood and this is characteristic of both human and animal bodies. It is believed that circulating mitochondria can easily pass through tissue barriers due to their small size (50–400 nm). The phenomenon of mitochondrial intercellular transfer, which is bidirectional, has been observed in vitro and in vivo, under both physiological and pathophysiological conditions, and among a variety of cells, including malignant tumor cells. Circulating cell-free intact mitochondria are thought to play an active biological and physiological role, as mitochondria are already known to be systemic mediators of intercellular communication, transmitting hereditary and non-hereditary biological components, including MtDN A. Mitochondrial components of cellular origin, including mitochondrial DNA, were detected in the extracellular space. There are about 50,000 times more copies of the mitochondrial genome than the nuclear genome in the blood plasma of healthy people. The researchers confirmed that mitochondrial cell-free DNA (McfDNA) is stable enough for detection and quantification, implying that there are stable structures protecting these DNA molecules. The circulating mitochondrial genome, which is released as a cell-free mitochondrial DNA, is recognized as a new biomarker of mitochondrial stress and signal transduction. McfDNA has become an attractive circulating biomarker because of its potential use in diagnostic programs for various diseases, e. g., diabetes, acute myocardial infarction, and cancer. There is no doubt that detection of circulating mitochondria and their DNA in body fluids opens up a new promising scientific direction in biology and medicine. The article analyzes modern scientific data devoted to proving the existence of extracellular mitochondria, their functions outside the cell and diagnostic value.
- 16 February 2024
- Published by QUASAR, LLC in Research and Practical Medicine Journal
- Vol. 11 (1) , 40-53
Open AccessExtracellular mitochondria as promising diagnostic agents
Nowadays, there is a new concept that says that mitochondria naturally circulate in the blood and this is characteristic of both human and animal bodies. It is believed that circulating mitochondria can easily pass through tissue barriers due to their small size (50–400 nm). The phenomenon of mitochondrial intercellular transfer, which is bidirectional, has been observed in vitro and in vivo, under both physiological and pathophysiological conditions, and among a variety of cells, including malignant tumor cells. Circulating cell-free intact mitochondria are thought to play an active biological and physiological role, as mitochondria are already known to be systemic mediators of intercellular communication, transmitting hereditary and non-hereditary biological components, including MtDN A. Mitochondrial components of cellular origin, including mitochondrial DNA, were detected in the extracellular space. There are about 50,000 times more copies of the mitochondrial genome than the nuclear genome in the blood plasma of healthy people. The researchers confirmed that mitochondrial cell-free DNA (McfDNA) is stable enough for detection and quantification, implying that there are stable structures protecting these DNA molecules. The circulating mitochondrial genome, which is released as a cell-free mitochondrial DNA, is recognized as a new biomarker of mitochondrial stress and signal transduction. McfDNA has become an attractive circulating biomarker because of its potential use in diagnostic programs for various diseases, e. g., diabetes, acute myocardial infarction, and cancer. There is no doubt that detection of circulating mitochondria and their DNA in body fluids opens up a new promising scientific direction in biology and medicine. The article analyzes modern scientific data devoted to proving the existence of extracellular mitochondria, their functions outside the cell and diagnostic value.
- 1 June 2022
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (16_suppl) , e15501
Factors of innate immunity in patients with colon cancer with different levels of circulating tumor cells.
E15501 Background: The purpose of this study was to demonstrate the importance of circulating tumor cells (CTCs) in the formation of immunosuppression in colon cancer. Methods: 200 patients with stage II-IV colon cancer underwent surgery as the first stage of treatment. Blood levels of CTCs were determined before surgery by flow cytometry using the CellSearch method (the sample was considered positive with CTCs > 3), as well as some indicators of innate immunity (NK cells, neutrophilic and monocytic phagocytosis). Results: Regardless of the stage, patients with CTCs had statistically significantly lower levels of NK lymphocytes (16.8±1.9 versus 22.3±1.8%, p≤0.05) compared with the absence of CTCs; on the contrary, levels of NKT cells in this group were higher than in the absence of CTCs (8.8±0.9 versus 5.0±1.0%, p≤0.05). The presence of CTCs was accompanied by higher levels of CD16dim56bright cells (13.1±3.2 versus 5.9±1.0% p≤0.05) with a lower content of CD16+56dim (82.5±3.6 versus 90.4±0.8%), and levels of perforin and granzyme were similar. The presence of CTCs was characterized by a higher percentage of phagocytic monocytes in the Phagotest test, as well as a higher percentage of monocytes and neutrophils capable of developing oxidative burst upon fMLF stimulation in the Phagoburst test (10.8±3.3 versus 3.2±1.5% and 5.1 ±0.8 vs. 2.0±1.1%, respectively; p≤0.05). A separate analysis of phagocytosis indicators by disease stages revealed that the presence of CTCs in patients was accompanied by stimulation of phagocytosis in local tumors and inhibition in advanced disease, however, in the latter case, the ability of granulocytes and monocytes to generate reactive oxygen species (ROS) was preserved and even increased. Conclusions: The presence of CTCs in patients with colon cancer is characterized by a redistribution of natural killer subpopulations with an increase in the blood levels of NKT cells, some of which have immunosuppressive activity, due to a decrease in NK cells, and an increase in CD16dim56bright and a decrease in CD16+56dim, apparently, indicates disturbance of their maturation. The established changes in the presence of CTCs indicate the inhibition of antitumor properties of the NK cell and phagocytic components of innate immunity in tumor cell circulation. The N-formylpeptide fMLF is known as a powerful neutrophil chemoattractant, stimulator of their migration and cytokine production, which plays a role in the development of inflammatory bowel diseases. The growth-promoting activity described for the similar antimicrobial protein LL-37 can be mediated through neutrophil migration and ROS production. Thus, the presence of CTCs has a negative impact on the parameters of NK cell and phagocytic components of innate cellular immunity in patients with colon cancer, which can serve as one of the strategies for survival and dissemination of the tumor.
- 1 June 2022
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (16_suppl) , e15501
Factors of innate immunity in patients with colon cancer with different levels of circulating tumor cells.
E15501 Background: The purpose of this study was to demonstrate the importance of circulating tumor cells (CTCs) in the formation of immunosuppression in colon cancer. Methods: 200 patients with stage II-IV colon cancer underwent surgery as the first stage of treatment. Blood levels of CTCs were determined before surgery by flow cytometry using the CellSearch method (the sample was considered positive with CTCs > 3), as well as some indicators of innate immunity (NK cells, neutrophilic and monocytic phagocytosis). Results: Regardless of the stage, patients with CTCs had statistically significantly lower levels of NK lymphocytes (16.8±1.9 versus 22.3±1.8%, p≤0.05) compared with the absence of CTCs; on the contrary, levels of NKT cells in this group were higher than in the absence of CTCs (8.8±0.9 versus 5.0±1.0%, p≤0.05). The presence of CTCs was accompanied by higher levels of CD16dim56bright cells (13.1±3.2 versus 5.9±1.0% p≤0.05) with a lower content of CD16+56dim (82.5±3.6 versus 90.4±0.8%), and levels of perforin and granzyme were similar. The presence of CTCs was characterized by a higher percentage of phagocytic monocytes in the Phagotest test, as well as a higher percentage of monocytes and neutrophils capable of developing oxidative burst upon fMLF stimulation in the Phagoburst test (10.8±3.3 versus 3.2±1.5% and 5.1 ±0.8 vs. 2.0±1.1%, respectively; p≤0.05). A separate analysis of phagocytosis indicators by disease stages revealed that the presence of CTCs in patients was accompanied by stimulation of phagocytosis in local tumors and inhibition in advanced disease, however, in the latter case, the ability of granulocytes and monocytes to generate reactive oxygen species (ROS) was preserved and even increased. Conclusions: The presence of CTCs in patients with colon cancer is characterized by a redistribution of natural killer subpopulations with an increase in the blood levels of NKT cells, some of which have immunosuppressive activity, due to a decrease in NK cells, and an increase in CD16dim56bright and a decrease in CD16+56dim, apparently, indicates disturbance of their maturation. The established changes in the presence of CTCs indicate the inhibition of antitumor properties of the NK cell and phagocytic components of innate immunity in tumor cell circulation. The N-formylpeptide fMLF is known as a powerful neutrophil chemoattractant, stimulator of their migration and cytokine production, which plays a role in the development of inflammatory bowel diseases. The growth-promoting activity described for the similar antimicrobial protein LL-37 can be mediated through neutrophil migration and ROS production. Thus, the presence of CTCs has a negative impact on the parameters of NK cell and phagocytic components of innate cellular immunity in patients with colon cancer, which can serve as one of the strategies for survival and dissemination of the tumor.
- 1 June 2022
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (16_suppl) , e15503
Immunological microenvironment in colon cancer patients with different phenotypes of cancer stem cells.
E15503 Background: The purpose of this study was to analyze the effect of the CD44+ and CD133+ co-expression in cancer stem cells (CSCs) on lymphocytic microenvironment of colon cancer (CC). Methods: 200 CC patients received surgery as the first stage of treatment. The percentage of CSCs with the expression of CD44+ and/or CD133+ markers was studied in the tumor homogenates by flow cytometry, as well as some indicators of local immunity (CD3+, CD4+, CD8+, T regs (CD4+CD25+CD127dim), CD19+, PD-1, PD-L1, Th0, Tm, CD16/56+ and immunophenotypic characteristics of tumor cells (PD-L1, MHC-ABC). Results: Gradation depending on the absence or presence of co-expression of CSC markers on tumor cells allowed identification of 11 statistically significant differences out of 17 studied parameters of tumor cells and their lymphocytic microenvironment. Co-expression of CSC markers was accompanied by higher percentage of T regs (7.3±0.4 versus 5.3±0.5%), together with lower levels of CD4+ cells. At the same time, a higher content of the total number of T-lymphocytes was noted due to CD8+ with an increase in the percentage of memory T cells and a decline in naive T lymphocytes within this subpopulation. In addition, the co-expression of CSC markers was accompanied by a lower content of PD-L1 (34.3±3.0 vs. 42.9±2.5%) on lymphocytes and its higher content on tumor cells (10.6±1.5 vs. 4.1±0.8%), while the PD-1 expression on lymphocytes was higher (38.4±3.7 versus 22.3±2.9%). The presence of CD44+CD133+ CSCs was also accompanied by lower percentage of tumor cells expressing MHC class I (60.4±4.9 vs. 79.3±7.6%), which characterized the inhibition of recognition processes, and increased levels of CD8+, perhaps, should be considered as compensatory. Conclusions: The lymphocytic microenvironment of CC in the presence of CSCs with the CD44+CD133+ immunophenotype seems to be more immunosuppressive, according to the increase in the local content of T regs and the decrease in MHC-ABC expression. Higher expression of PD-L1 on tumor cells and PD-1 on lymphocytes allows activation of the PD-1/PD-L1 interaction, which enhances the immunosuppressive and growth-stimulating properties of the tumor microenvironment, but at the same time, makes tumor cells adequate targets for immunotherapy with immune checkpoint inhibitors.
- 1 June 2022
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (16_suppl) , e15503
Immunological microenvironment in colon cancer patients with different phenotypes of cancer stem cells.
E15503 Background: The purpose of this study was to analyze the effect of the CD44+ and CD133+ co-expression in cancer stem cells (CSCs) on lymphocytic microenvironment of colon cancer (CC). Methods: 200 CC patients received surgery as the first stage of treatment. The percentage of CSCs with the expression of CD44+ and/or CD133+ markers was studied in the tumor homogenates by flow cytometry, as well as some indicators of local immunity (CD3+, CD4+, CD8+, T regs (CD4+CD25+CD127dim), CD19+, PD-1, PD-L1, Th0, Tm, CD16/56+ and immunophenotypic characteristics of tumor cells (PD-L1, MHC-ABC). Results: Gradation depending on the absence or presence of co-expression of CSC markers on tumor cells allowed identification of 11 statistically significant differences out of 17 studied parameters of tumor cells and their lymphocytic microenvironment. Co-expression of CSC markers was accompanied by higher percentage of T regs (7.3±0.4 versus 5.3±0.5%), together with lower levels of CD4+ cells. At the same time, a higher content of the total number of T-lymphocytes was noted due to CD8+ with an increase in the percentage of memory T cells and a decline in naive T lymphocytes within this subpopulation. In addition, the co-expression of CSC markers was accompanied by a lower content of PD-L1 (34.3±3.0 vs. 42.9±2.5%) on lymphocytes and its higher content on tumor cells (10.6±1.5 vs. 4.1±0.8%), while the PD-1 expression on lymphocytes was higher (38.4±3.7 versus 22.3±2.9%). The presence of CD44+CD133+ CSCs was also accompanied by lower percentage of tumor cells expressing MHC class I (60.4±4.9 vs. 79.3±7.6%), which characterized the inhibition of recognition processes, and increased levels of CD8+, perhaps, should be considered as compensatory. Conclusions: The lymphocytic microenvironment of CC in the presence of CSCs with the CD44+CD133+ immunophenotype seems to be more immunosuppressive, according to the increase in the local content of T regs and the decrease in MHC-ABC expression. Higher expression of PD-L1 on tumor cells and PD-1 on lymphocytes allows activation of the PD-1/PD-L1 interaction, which enhances the immunosuppressive and growth-stimulating properties of the tumor microenvironment, but at the same time, makes tumor cells adequate targets for immunotherapy with immune checkpoint inhibitors.